Kroon Bb
Impact in
- Oncology top 10%
- Cutaneous Melanoma Detection and Management
- Vascular Tumors and Angiosarcomas
-
- Sarcoma Diagnosis and Treatment
Papers in
- Oncology 7
- Cutaneous Melanoma Detection and Management 6
- Vascular Tumors and Angiosarcomas 1
-
- Sarcoma Diagnosis and Treatment 2
- Co-authors
- Emiel J. Rutgers (1 shared paper)E. Gortzak (1 shared paper)Eggermont Am (4 shared papers)F. Rosenkaimer (1 shared paper)Philippe Autier (1 shared paper)D. Liénard (1 shared paper)van Dongen Ja (3 shared papers)P Rümke (1 shared paper)
- Journals
- PubMed (11 papers)
- Partner nations
- Netherlands
In The Last Decade
Kroon Bb
11 papers receiving 417 citations
Peers
Comparison fields: 5 of 42
- Oncology 249
- Pulmonary and Respiratory Medicine 209
- Dermatology 50
- Rheumatology 55
- Pathology and Forensic Medicine 53
Countries citing papers authored by Kroon Bb
This map shows the geographic impact of Kroon Bb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kroon Bb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kroon Bb more than expected).
Fields of papers citing papers by Kroon Bb
This network shows the impact of papers produced by Kroon Bb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kroon Bb. The network helps show where Kroon Bb may publish in the future.
Co-authors
The 9 scholars most cited alongside Kroon Bb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Dermatofibrosarcoma protuberans: treatment and prognosis. | 1992 | 209 |
| 2 | Isolated perfusion of the limb with high-dose tumour necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma) and melphalan for melanoma stage III. Results of a multi-centre pilot study. | 1994 | 87 |
| 3 | Reproducibility of lymphoscintigraphy for lymphatic mapping in cutaneous melanoma. | 1996 | 69 |
| 4 | Limb recurrence-free interval and survival in patients with recurrent melanoma of the extremities treated with normothermic isolated perfusion. | 1994 | 53 |
| 5 | Elective lymph node dissection in melanoma: still a controversial issue. | 1991 | 9 |
| 6 | Is there an indication for a double perfusion schedule with melphalan for patients with recurrent melanoma of the limbs? | 1994 | 7 |
| 7 | Regional isolated perfusion with melphalan for patients with subungual melanoma. | 1993 | 6 |
| 8 | [Alveolar soft tissue sarcoma]. | 1981 | 3 |
| 9 | [Loa loa: "the eye worm"]. | 1981 | 1 |
| 10 | [Revised consensus melanoma of the skin]. | 1990 | 1 |
| 11 | [Origin of bacteria in bile; a prospective bacteriological study]. | 1980 | 1 |
About Kroon Bb
Kroon Bb is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Pharmaceutical Science, having authored 11 papers that have together received 446 indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (6 papers), Sarcoma Diagnosis and Treatment (2 papers), Microbial Inactivation Methods (1 paper), Optical Coherence Tomography Applications (1 paper), Vascular Tumors and Angiosarcomas (1 paper), Beetle Biology and Toxicology Studies (1 paper), Advancements in Transdermal Drug Delivery (1 paper) and Melanoma and MAPK Pathways (1 paper). The work is most often cited by research in Oncology (249 citations), Pulmonary and Respiratory Medicine (209 citations), Dermatology (50 citations), Rheumatology (55 citations) and Pathology and Forensic Medicine (53 citations). Kroon Bb has collaborated with scholars based in Netherlands. Frequent co-authors include Emiel J. Rutgers, E. Gortzak, Eggermont Am, F. Rosenkaimer, Philippe Autier, D. Liénard, van Dongen Ja, P Rümke and Ruiter Dj. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.